Business · 02/10/2023
FDA Announces Final Guidance for Dose Banding on Prescription Drug Labels
The FDA has released a final guidance to help pharmaceutical companies incorporate dose banding information into the labels of injectable drug products, based on weight or body surface area, for certain marketing applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →